Maribavir
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 328 publications
Targeting the US21 viroporin of human cytomegalovirus by calcium channel blockers as a new antiviral strategy.
Journal: Current research in microbial sciences
Published: May 04, 2026
Epidemiology and clinical management of cytomegalovirus infection in transplant recipients in Central and Eastern Europe - a physician survey.
Journal: Antiviral therapy
Published: April 29, 2026
Intravitreal foscarnet is an effective adjunct after systemic therapy failure in pediatric antiviral-resistant cytomegalovirus retinitis.
Journal: The Journal of international medical research
Published: April 16, 2026
Maribavir for cytomegalovirus retinitis: A case series and review of the literature.
Journal: AJO international
Published: April 06, 2026
Drug interaction between maribavir and rifampin: a case report.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 28, 2026
The Troll Is Weakened but Not yet Defeated: An Update on Cytomegalovirus Management in Transplantation From the International CMV Symposium 2025.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: March 23, 2026
Case report:Maribavir for refractory CMV infection in 2 pediatric HSCT recipients.
Journal: Diagnostic microbiology and infectious disease
Published: March 23, 2026
Analysis of healthcare resource utilization before and after initiation of maribavir for cytomegalovirus treatment.
Journal: Journal of medical economics
Published: March 11, 2026
Case report: Maribavir as salvage therapy for multidrug-resistant CMV DNAemia in a non-transplant patient with ocular cicatricial pemphigoid.
Journal: IDCases
Published: March 07, 2026
Management of cytomegalovirus in kidney transplantation in light of the new international recommendations
Journal: Nephrologie & therapeutique
Published: February 11, 2026
Maribavir for Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients: A Case Series.
Journal: IJU case reports
Published: February 11, 2026
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study.
Journal: The Lancet. Infectious diseases
Published: January 12, 2026
Last Updated: 06/30/2026